Cargando…
Considerations for determining safety of probiotics: A USP perspective
A history of safe use is a backbone of safety assessments for many current probiotic species, however, there is no global harmonization regarding requirements for establishing probiotic safety for use in foods and supplements. As probiotic manufacturers are increasingly seeking to use new strains, n...
Autores principales: | Roe, Amy L., Boyte, Marie-Eve, Elkins, Chris A., Goldman, Virginia S., Heimbach, James, Madden, Emily, Oketch-Rabah, Hellen, Sanders, Mary Ellen, Sirois, Jay, Smith, Amy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292223/ https://www.ncbi.nlm.nih.gov/pubmed/36206977 http://dx.doi.org/10.1016/j.yrtph.2022.105266 |
Ejemplares similares
-
United States Pharmacopeia (USP) Safety Review of Gamma-Aminobutyric Acid (GABA)
por: Oketch-Rabah, Hellen A., et al.
Publicado: (2021) -
United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts
por: Oketch-Rabah, Hellen A., et al.
Publicado: (2020) -
Probiotics and microbiota composition
por: Sanders, Mary Ellen
Publicado: (2016) -
Improving End-User Trust in the Quality of Commercial Probiotic Products
por: Jackson, Scott A., et al.
Publicado: (2019) -
Paper incompletely describes evidence-based usage of probiotics
por: Sanders, Mary Ellen, et al.
Publicado: (2017)